Promoting a Healthier Tomorrow

The high demand for epidemiology at Biogen and the internal resource constraints have created the need for outsourcing . Our highly skilled and experienced team of epidemiologists set a high bar for the capability of an outsourced partner. Bohn Epidemiology, under the leadership of Rhonda Bohn, has exactly and expertly fit our needs. Rhonda’s staff of epidemiologists consistently produce high quality reports, on time and ready for delivery to our internal stakeholders. Bohn Epidemiology is a collaborative, reliable, efficient organization of well-qualified epidemiologists and has become an indispensable resource for the Biogen Epidemiology function. It is a pleasure to work with Rhonda and her team.

We worked with Rhonda on a number of projects in a strategic, operational and regulatory capacity. Each and every time we found her to be a reliable and competent professional, who understands a sense of urgency and executes the highest quality deliverables.

Rhonda and I have collaborated together in a variety of settings. We conducted research together and published seminal papers on the health economics of hemophilia and the impact of home therapy. I have also seen and been involved in her speaking engagements in epidemiology as they relate to hemophilia. She is eloquent, precise and charming. She participated in international committees to devise guidelines in the field of hemophilia; her participation and concepts were right on target.

Without any question, the quality of Rhonda’s work has been first rate. Our company commissioned the development of a 44-page white paper to describe the incidence and prevalence of four in-line rare diseases. Rhonda conducted a comprehensive and targeted literature review that identified population-based epidemiology studies for each disease state and combined prevalence estimates from previous database studies. This work was extremely well received within the R&D organization and was an integral part of marketing and commercial assessments.

Rhonda and I have worked together from 2001 - 2014. It was one of the most enjoyable and productive collaborative working relationships I have had with a consultant. Rhonda helped me in many ways; she covered all therapeutic areas and worked independently (conducting literature reviews, designing studies, preparing study protocols and reports, monitoring studies, and to working on my behalf with third party experts and providing strategic advice). She also helped advise junior staff in various aspects regarding epidemiological approaches to study design. Regardless of the type of work I requested, she always completed the work on time and with the highest quality. I completely trust and rely on Rhonda as a consultant. I was frequently amazed at how little time she claimed she had used for each consulting project. Rhonda is surely one of the best working partners one can expect of a consultant.

Dr. Bohn has proven to be an invaluable expert to our Real World Evidence Team. She has contributed to the design and implementation of observational research. Also her strategic expertise has been indispensable in identifying and developing the necessary Real World Evidence Strategy for some of our key assets. Her significant methodologic and strategic expertise coupled with her impressive network have proven invaluable to the Epidemiology therapeutic heads.

I’ve been working with Rhonda for over 10 years, usually on highly complicated multi-site safety and effectiveness studies. She has the vision and skill to navigate complex research designs as well as institutional relationships to see a project through to successful completion.

I have been conducting pharmacoepidemiology and pharmacoeconomics research with Rhonda since 1991, when she joined our research group as one of its earliest epidemiologists. She played a pivotal role in developing the large observational datasets that we are still using today, and made many important methodological contributions to that work. We have gone on to publish a great number of papers together, demonstrating her versatility across many domains of the field. Our team continues to collaborate with her 25 years later and to benefit from her wealth of experience and collegiality.

Rhonda’s team has provided critical support to the Sage HEOR team for the past four years to help us better understand the epidemiology and burden of a range of CNS indications. The work provided by her team has always been thorough, robust, and well executed. The depth of knowledge regarding major depressive disorder, in particular, has been an exceptional resource.